Total Payments
$64,263
2022 Payments
$1,721
Companies
11
Transactions
65
Payment Breakdown by Category
Consulting$54,091 (84.2%)
Other$5,001 (7.8%)
Travel$4,269 (6.6%)
Food & Beverage$630.47 (1.0%)
Education$272.21 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $54,091 | 29 | 84.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,001 | 3 | 7.8% |
| Travel and Lodging | $4,269 | 17 | 6.6% |
| Food and Beverage | $630.47 | 11 | 1.0% |
| Education | $272.21 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $33,974 | 36 | $0 (2021) |
| Genentech USA, Inc. | $9,811 | 8 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $9,150 | 4 | $0 (2017) |
| Biogen, Inc. | $4,116 | 3 | $0 (2020) |
| PFIZER INC. | $1,772 | 5 | $0 (2019) |
| F. Hoffmann-La Roche AG | $1,751 | 1 | $0 (2019) |
| Eli Lilly and Company | $1,564 | 3 | $0 (2022) |
| H. Lundbeck A S | $1,026 | 1 | $0 (2017) |
| Lilly USA, LLC | $950.00 | 2 | $0 (2018) |
| AbbVie Inc. | $79.56 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,721 | 2 | Genentech USA, Inc. ($1,215) |
| 2021 | $2,264 | 4 | Genentech USA, Inc. ($1,163) |
| 2020 | $21,785 | 25 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($17,590) |
| 2019 | $15,749 | 16 | Genentech USA, Inc. ($7,434) |
| 2018 | $5,696 | 8 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($3,796) |
| 2017 | $17,048 | 10 | Merck Sharp & Dohme Corporation ($9,150) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2022 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $505.57 | General |
| 04/21/2022 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,215.00 | General |
| 11/09/2021 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $108.58 | General |
| 09/27/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $331.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2021 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,162.50 | General |
| 01/21/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $662.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2020 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| 10/02/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $7,460.74 | General |
| Category: PSYCHIATRY | ||||||
| 08/04/2020 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $866.00 | General |
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $4,382.44 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $275.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $87.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $45.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $37.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $35.62 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $33.06 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $4,382.44 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $171.04 | General |
| Category: PSYCHIATRY | ||||||
| 02/12/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $79.56 | General |
| 01/28/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: PSYCHIATRY | ||||||
| 01/28/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $37.00 | General |
| Category: PSYCHIATRY | ||||||
| 01/28/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $275.00 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Howard Fillit, MD
Dr. Howard Fillit, MD is a Geriatric Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689770141.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Fillit, MD has received a total of $64,263 in payments from pharmaceutical and medical device companies, with $1,721 received in 2022. These payments were reported across 65 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($54,091).
Ad
Practice Information
- Specialty Geriatric Medicine
- Location New York, NY
- Active Since 09/15/2006
- Last Updated 08/19/2008
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689770141
Products in Payments
- REXULTI (Drug) $24,103
- BREXPIPRAZOLE (Drug) $3,796
- Non-Covered Product (Drug) $1,751
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in New York
Lisa Babitz, Md, MD
Geriatric Medicine — Payments: $7,071
Geriatric Medicine $7,071
Dr. Kenneth Mercer, Md Mph, MD MPH
Geriatric Medicine — Payments: $4,806
Geriatric Medicine $4,806
Laleh Moazen, M.d, M.D
Geriatric Medicine — Payments: $4,667
Geriatric Medicine $4,667
Laszlo Feher, Do, DO
Geriatric Medicine — Payments: $4,640
Geriatric Medicine $4,640
John Getsos, M.d, M.D
Geriatric Medicine — Payments: $3,449
Geriatric Medicine $3,449
Dr. Eric Manheimer, Md, MD
Geriatric Medicine — Payments: $3,396
Geriatric Medicine $3,396